Full Text View
Tabular View
No Study Results Posted
Related Studies
Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo
This study has been completed.
Study NCT01354717   Information provided by Spear Pharmaceuticals

First Received on May 14, 2011.   Last Updated on June 3, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Actinic Keratoses
Additional conditions recognized in this trial
Keratosis
Keratosis, Actinic
More general conditions related to this trial
Neoplasms
Precancerous Conditions
Skin Diseases
Interventions listed in this trial
0.5%, 5-fluorouracil cream
.5% 5-fluorouracil cream
placebo cream
Additional drug interventions recognized in this trial
Fluorouracil
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Spear Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services